- Category: Lawsuit News Alerts
Laxative Side Effects Lawsuit
FDA Warns of Fatal Laxative Side Effects Following Death Reports
Laxatives commonly used to treat constipation may result in fatal side effects, according to the Food and Drug Safety Administration. A public health alert posted by the U.S. health regulator on its website on January 2014 says that over-the-counter laxatives “are potentially dangerous if dosing instructions or warnings on the Drug Facts label are not properly followed or when there are certain coexisting health conditions.” There are reports of at least 13 deaths and dozens of severe side effects caused by the constipation drug overdose registered through the MedWatch adverse reporting system.
Laxatives are available in various forms, each containing different ingredients. The most reported of these constipation medications to the FDA for fatal side effects include saline laxatives that contain sodium phosphate and are available in enema form or as generic phospho-soda. Other types of laxatives available with glycerin suppositories, mineral oil, soluble psyllium fiber, and plant fiber methylcellulose also pose health risks, which are considered to be of a lower level.
According to the FDA, sodium phosphate laxatives sold under "Fleet" brand name or as generic products or store brands have been reported for causing fatalities and serious side effects. Consumers have experienced severe dehydration following use of these constipation medications. There have also been reports of electrolyte anomalies leading to potential kidney damage and other fatal consequences.
Fleet withdrew its oral non-prescription laxatives containing higher doses in 2008 after the FDA issued warnings citing potential side effects. However, the company continued with the enemas claiming it as safe product.
Laxative Side Effects for Adult, Children, Preexisting Health Conditions
The FDA wants consumers to pay attention to drug label instructions mentioned on the over-the-counter laxatives prior to using them to overcome constipation. For example, a sodium phosphate laxative, as mentioned on its label, must be limited to a dose per day and should not be used continuously for more than three days at a stretch. “Equally important, consumers who do not have a bowel movement after taking an oral or rectal dose should not take another dose of the product,” the FDA warning reads.
New regulatory instructions on Laxatives advise that adults above 55 and children should avoid using the constipation medication unless prescribed by health care professionals, as they are at an increased risk of side effects. Those already facing dehydration may face fatal consequences as laxatives draw water from various body parts increasing the dehydration level. The onset of dry mouth and light headedness along with thirst are common symptoms when laxative side effects cause acute dehydration.
The federal regulator has cautioned that people with the following preexisting conditions are at a greater risk of harmful laxative side effects.
Drowsiness and renal disorder
Leg and feet swelling
Delayed bowel emptying
High blood pressure
Taking nonsteroidal anti-inflammatory drugs
Treated with diuretics or fluid medicines
Having colon inflammation
- Category: Lawsuit News Alerts
Hip Replacement Recall Lawsuit Settlement
Hip Implant Lawsuit: Johnson & Johnson Reportedly Offers $4 Billion Payment
On November 13, a report on Bloomberg claimed that Johnson & Johnson has struck a deal of $4 billion to settle thousands of DePuy hip implant lawsuits. It roughly translates into about $350,000 payment per litigant. Though there is no official word from the company or its subsidiary DePuy Orthopaedics, settlement details are likely to be announced next week, according to two lawyers privy to the settlement.
The settlement, according to sources, will cover 7,000 to 8,000 litigants who had to undergo revision or replacement surgeries following the failure of DePuy ASR hip implants. The tentative deal is expected to leave those litigants who are yet to replace the DePuy systems despite suffering from adverse effects. Johnson & Johnson faces over 12,000 hip implant lawsuits filed over ASR and Pinnacle brand hip replacement devices. This is going to create space for future litigations and the manufacturer will be forced to pay those removing DePuy’s implanted hip devices.
Though each litigant, on an average, is expected to be awarded $350,000, the final settled amount may vary depending on medical condition of plaintiffs. The foremost contention put forward by clients is that the design defects in these hip implants allow friction between the metal parts that corrode the implant causing it to fail prematurely and release metal debris into blood, putting users at the risk of metal poisoning and tissue death.
DePuy Hip Implant Lawsuits: Background
DePuy Orthopaedics, owned by Johnson & Johnson, faces over 12,000 hip implant lawsuits following failures and subsequent recall of its ASR and Pinnacle hip replacement systems. The Pinnacle metal-on-metal hip replacement system was introduced in 2001. In 2005, DePuy came up with ASR hip implants and the FDA allowed it “fast track” approval under the 510k process without trial following claims of similarity with Pinnacle hip implants.
DePuy issued a global recall of 93,000 ASR implants in August 2010 following numerous complaints to the FDA. Between 2006 and 2009, more than 600 failure and adverse event complaints were registered on MedWatch reporting system. Patients implanted with ASR and Pinnacle systems experienced early failure, metal toxicity, loss of sensory and cognitive capabilities, pain, immobility, long-term osteolysis, inflammation due to design defects and underwent revision surgeries leading to financial and health problems. One in every eight that had ASR hip systems implanted, according to experts, experienced device failure within a year of the surgery. Similarly, there were over 1,000 Pinnacle hip implant complaints on the MedWatch program.
DePuy Hip Implant Lawsuit Update
About 7,800 DePuy ASR hip lawsuits have been filed in various U.S. courts while 4,200 DePuy Pinnacle hip lawsuits are pending for trial. In October 2013, Johnson & Johnson settled two DePuy hip implant lawsuits just days before their set trial schedule. The first one filed in a San Francisco Superior Court was set for a late October hearing while the second one was awaiting trial in a New Jersey state court.
In March 2013, the first state trial of DePuy hip implant lawsuit led to a plaintiff from California being awarded $8.3 million in damages. The federal trial of DePuy hip implant lawsuit consolidated at an Ohio court is expected to begin in January 2014. There are reports that a Johnson & Johnson offer of $200,000 in damages were rejected by plaintiffs and that the company is considering to offer about $300,000 per lawsuit to settle.
Stryker Hip Implant Lawsuit: Settlement Amount To Exceed $1 Billion
Stryker Corporation also expects to dole out around $1 billion to settle thousands of hip implant lawsuits filed in the United States seeking product liability following recalls of its Rejuvenate and ABG II systems. According to the latest estimates disclosed by the Michigan-based medical technologies firm in its third quarter earning and the October financial report, the final settlement of hip replacement system lawsuits may lead to compensation payments between $700 million and $1.13 billion. The latest figures are almost double of $400 to $660 million estimates made by the company in July 2013. The expected settlement is likely to exceed the previous record of $1 billion compensation paid by Sulzer in 2001 for its defective hip implants.
Stryker Hip Implant Lawsuit: Background
- Category: Lawsuit News Alerts
Linkedin Lawsuit Over Email Privacy
LinkedIn Privacy Violation Lawsuit
Four LinkedIn users have initiated a privacy violation lawsuit claiming that the business professional networking website accessed their email accounts illegally to mine out contact details and send spam mails. The LinkedIn lawsuit filed in a San Jose federal court on September 17 alleges that Linkedln downloaded addresses from user email accounts without their express consent and sent "endorsement emails" to their friends mentioning the name and likeness of users.
First of such explosive claims against the 238-million user business social network, the LinkedIn lawsuit accuses the website of “breaking into” Gmail, Yahoo, and other user e-mail accounts without permission and sending endorsement emails from them, pretending to be the real user. Such practice of “hacking,” according to the complaint, is motivated by marketing practices to gain commercial benefits and extend its reach.
Spread over 46 pages, the detailed complaint highlights several instances where users made complaints to LinkedIn against sending unqualified and illegal endorsement messages to email accounts of clients, friends, spouses, forgotten girlfriends or boyfriends, business partners and even opposing counsels without their consent. The plaintiffs have also alleged that the social networking site’s Terms of Services did not have satisfactory details indicating such data-gathering and LinkedIn "provides no functional way to stop multiple subsequent advertising emails from being sent."
- Category: Recall Lawsuit
Stryker Rejuvenate Hip Replacement Implant Recall Lawsuit
Stryker Rejuvenate Hip Implant Lawsuits
On January 25, a Stryker Rejuvenate class action lawsuit was filed in a south Florida federal court seeking free treatment and medical monitoring for people implanted with the recalled metal hip replacement devices. Michigan-based Stryker Orthopedics recalled its metal Rejuvenate Modular hip implants in June 2012 following widespread reports of metal poisoning, local tissue reactions, pain, premature device failure, and early modular-neck junction corrosion attributed to its design defects. The FDA received as many as 60 complaints on the hip implant failure, metallosis, infection, and bone necrosis in the four months preceding the recall.
An estimate released by Stryker Orthopedics in January 2013 puts the total costs the manufacture has to pay for personal injury lawsuits filed following the hip system recall at $390 million. The number of Stryker Rejuvenate hip lawsuits is expected to rise in the months ahead as more patients are coming forward seeking compensation for injury, pain, side effects, suffering caused by the device and reimbursement for medical and implant costs. In January 2013, the Supreme Court of New Jersey ordered for consolidated proceeding of all Stryker hip product liabilities filed in the state courts.
Stryker Rejuvenate Hip Implant: The System and Drawbacks
Stryker Rejuvenate hip implants were introduced in the United States in February 2010 following authorization through the FDA’s controversial 510(k) approval process. The procedure, which is being subject to strong criticism, permits introduction of new drugs or medical devices “substantially equivalent” to similar products already approved by the FDA for marketing and consumer use. Stryker introduced the Rejuvenate hip implants claiming that the system was similar to Profemur hip implants produced by Wright Medical Technology in design and offered superior intraoperative efficiency and flexibility.
The Stryker Rejuvenate hip implant system consists of the following three components
- A chromium-cobalt stem
- A non-metallic ball
- A titanium neck
The design of Stryker Rejuvenate hip implant system has been found defective and causes rubbing of metal components of the system against each other that discharges metal particles into the blood stream, putting users at the increased risk of metal poisoning. Many patients using these metal artificial hips have been diagnosed with high blood chromium and blood cobalt levels. Continuous and unusual fretting disables the metal parts early, and the devices last less than a quarter of the 15-year life span claimed by the manufacturer. Metal particles released from the artificial hip implants also cause infection, bone necrosis, and scar tissue and pseudotumor formation in and around the hip area.
The Wring Profemur hip implants with which Stryker Rejuvenate systems share design similarity have been subject to many lawsuits for their early failure, loosening of implants, consistent hip pain, and problem in walking or standing.
Stryker Rejuvenate Hip Implant: Major Side Effects
- Metallosis and toxicity
- Thyroid disorders
- Cardiovascular problems
- Hip area inflammation
- Metal poisoning leading to nervous system, gastrointestinal, cognitive disorders, vision and hearing problems, skin rashes, myocardiopathy, hypothyroidism, and death
- Sharp rise in cobalt and chromium ions in blood
- Peripheral soft tissue damage
- Nerve palsy and other side effects impacting normal nervous system functioning
- Device dislocation and chronic pain
- Premature device failure leading to secondary or revision surgery
- Bone necrosis and fractures
Stryker Rejuvenate Hip Implant Warnings
More than 17,000 complaints have been made through the FDA adverse reporting system, highlighting side effects and failure of metal hip implants in the last one decade. In May 2011, the FDA asked all metal artificial hip implant manufacturers, including Stryker, to conduct comprehensive safety assessment of its products fully reflecting safety concerns of consumers raised through complaints to the regulator.
- Category: Side Effects Lawsuit
Acetaminophen Tylenol Side Effects Lawsuit Attorney
According to a study done by Seattle-based Fred Hutchinson Cancer Research Center, long-term use of painkiller acetaminophen puts users at risk of developing blood cancers. The survey based on a six-year study of 65,000 people above 50 years found that several of chronic acetaminophen users developed blood cancer after taking the drug over a long period of time. Those who took acetaminophen four times or more in a week for four years became twice prone to developing blood malignancies than those who did not use the Tylenol drug.
Acetaminophen, popularly known as Tylenol, is the most commonly used pain killer and anti-inflammatory over-the-counter and prescription drug. It is a component of more than 100 medicines. An overdose of the drug is linked to several health concerns, including liver failure. In recent years, the FDA has issued warnings to drug manufacturers in the United States to use the lowest possible doses of acetaminophen in their products. The federal regulator is concerned over the incidence of its use for variety of medications.
In 2009, the FDA added nonprescription and prescription requirements to provide information regarding hepatotoxicity caused by acetaminophen . It even held a meeting in June 2009 on addressing the problem of liver injury linked to the use of acetaminophen. It is considering the possibility of removing the drug from popular analgesic combination products or lowering its doses. Recently, the drug